Christopher Sjöwall

Senior Associate Professor

Linköping University

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christopher Sjöwall is a Senior Associate Professor at Linköpings universitet in Sweden. His research focuses on autoimmune diseases, particularly systemic lupus erythematosus and primary Sjögren's disease, with recent publications exploring myocardial contraction, genetic associations, and autoantibody targets. He employs innovative methodologies such as speckle tracking echocardiography and population-based studies to advance understanding in these fields.

Articles (27)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (18)

Marie Larsson

Professor

Linköping University

SWEDEN

Christopher Sjöwall

Research Interests

Explore related searches

Contact this professor

About

Articles (27)

Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world setting

Development and evaluation of a Register-Based Organ Damage Index in systemic lupus erythematosus: a nationwide, population-based study from Sweden

Heterogeneous myocardial contraction detected by speckle tracking echocardiography in systemic lupus erythematosus is associated with complement protein C4: a cross-sectional study from a Swedish tertiary referral centre

Patients with systemic lupus erythematosus (SLE) have an increased bisphenol A methylation score linked to SLE risk genes and selected clinical subphenotypes

A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren’s disease

Mapping autoantibody targets of full-length C-reactive protein in systemic lupus erythematosus: importance for neutrophil function and classical complement activation.

Variants in the DDX6-CXCR5 autoimmune disease risk locus influence the regulatory network in immune cells and salivary gland.

Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis

The prevalence of neutropenia and association with infections in patients with systemic lupus erythematosus: a Swedish single-center study conducted over 14 years

Unraveling The Genetics of Shared Clinical and Serological Manifestations in Systemic Inflammatory Autoimmune Diseases

Immune Mechanisms and Biomarkers in Systemic Lupus Erythematosus

Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in SLE: a cross-sectional study

Autoantibodies to joint-related peptides as predictive markers in early rheumatoid arthritis

Retention rate of a novel autoinjector e-Device introduced to patients with chronic arthritis treated with certolizumab pegol in clinical practice: an observational implementation study

Factors Associated with Survival and Discontinuation of Anti-Malarial Agents in Systemic Lupus Erythematosus: Results from a Tertiary Swedish Referral Centre

Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy.

Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up

Doubtful Clinical Value of Subtyping Anti-U1-RNP Antibodies Regarding the RNP-70 kDa Antigen in Sera of Patients with Systemic Lupus Erythematosus

Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials

Antigen-presenting autoreactive B cells activate regulatory T cells and suppress autoimmune arthritis in mice.

Pentameric C-reactive protein is a better prognostic biomarker and remains elevated for longer than monomeric CRP in hospitalized patients with COVID-19.

Epidemiology and Damage Accrual of Systemic Lupus Erythematosus in Central Sweden: A Single‐Center Population‐Based Cohort Study Over 14 Years From Östergötland County

Effect of Belimumab on Preventing <i>de novo</i> Renal Lupus Flares.

Plasma Osteopontin Reflects Tissue Damage in Acute Pancreatitis

Extracellular vesicles opsonized by monomeric C-reactive protein (CRP) are accessible as autoantigens in patients with systemic lupus erythematosus and associate with autoantibodies against CRP.

Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosus.

Serum levels of soluble urokinase plasminogen activator receptor in juvenile idiopathic arthritis: a single-center Swedish case-control study

Collaborators (18)

Marie Larsson

Ingrid Lundberg

Marcus Bendtsen

Marie Wahren-Herlenius

Christian Michel Beusch

Elisabet Svenungsson

Lars Rönnblom

Marika Kvarnström

Alf Kastbom

Örjan Dahlström

Solbritt Rantapää Dahlqvist

Todor Dzhendov

David Kylhammar

Leonid Padyukov

Alvaro Gomez

Ioannis Parodis

Johan Nordgren

Daniel Appelgren

Make your next move.